FindTrial
Sign In

Screening and identification of serum MicroRNAs associated with radiosensitivity in nasopharyngeal carcinoma

Identification of genes and microRNAs associated with radioresistance and network interaction in nasopharyngeal carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17011888
Enrollment
Unknown
Registered
2017-07-06
Start date
2017-07-15
Completion date
Unknown
Last updated
2017-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nasopharyngeal carcinoma

Interventions

radioresistant:radiotherapy
radiotherapy:radiotherapy

Sponsors

The Affiliated Tumor Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) patients informed consent to participate in clinical trials, and accept follow-up; 2) patients with newly diagnosed NPC and had no prior anti-tumor treatment; 3) aged between 18~70 years old.

Exclusion criteria

Exclusion criteria: 1) MRI check contraindications; 2) can not accept radiotherapy .

Design outcomes

Primary

MeasureTime frame
Tumor Size;—

Countries

China

Contacts

Public ContactSong Qu

Graduate School of Guangxi Medical University

13607887386@163.com+86 13607887386

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026